In this video, Ola Landgren, MD, PhD, Sylvester Comprehensive Cancer Center & University of Miami, Miami, FL, shares his excitement about the upcoming Miami Myeloma MRD Meeting 2025, which will be held on April 11, 2025, in Miami, FL, and virtually. The event will bring together experts to discuss the use of measurable residual disease (MRD) for multiple myeloma (MM) in clinical and trial settings and will aid in furthering the understanding of recent advances and novel MRD technologies being developed and investigated. This interview took place virtually.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.